DRUG:CNSX
Bright Minds Biosciences Inc
CAD 70.94
arrow_upward
+0.87%(+0.61) 1H
1 Okt, 4:00:00 PTG GMT-4 · CAD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk DRUG...
Buka
CAD 69.20
Tinggi
CAD 70.94
Rendah
CAD 69.20
Permodalan Pasaran
699.76J
Purata volum
863.00
Volum
402.00
tgi 52 mgu
CAD 170.00
rdh 52 mgu
CAD 69.20
EPS
-CAD 2.90
Bilangan pekerja
26
Buka
CAD 69.20
Tinggi
CAD 70.94
Rendah
CAD 69.20
Permodalan Pasaran
699.76J
Purata volum
863.00
Volum
402.00
tgi 52 mgu
CAD 170.00
rdh 52 mgu
CAD 69.20
EPS
-CAD 2.90
Bilangan pekerja
26
Cerita berita
Daripada sumber web dan rakan kongsi berita
TipRanks
·
21 jam lalu
Bright Minds Deepens Prader-Willi Focus as BMB-101 Advances in Phase 2 Trial
Profil
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
Perihal Bright Minds Biosciences Inc